Antonia has earned a reputation as an innovative, sought-after IP lawyer who is highly strategic and uniquely focused on life sciences companies with multidisciplinary technologies at the intersection of biotechnology, devices and high tech.
She’s built successful international IP portfolios from the ground up for startup and emerging companies in both life sciences (diagnostics, therapeutics, medical devices) and in software (including for Facebook and other household names), and at the intersection of the two (bioinformatics, digital health). Her years of work in patent litigation representing life sciences and software companies also lend Antonia a litigator’s perspective on patent drafting.
'Antonia is an excellent patent attorney,’ according to commentators. ‘She provides a high level of client service, is knowledgeable about the subject matter area, and delivers work product on time and in budget.’"
Chambers USA
2022 Edition
When it comes to technical savvy, Antonia’s practice focuses on companies in the life sciences and health space, including in diagnostics and therapeutics. She has a particular focus on multidisciplinary life sciences companies, with technologies crossing over into more than one domain, e.g., biotech, device, and/or software.
When it comes to technical savvy, Antonia’s practice focuses on companies in the life sciences and health space, including in diagnostics and therapeutics. She has a particular focus on multidisciplinary life sciences companies, with technologies crossing over into more than one domain, e.g., biotech, device, and/or software.
As Fenwick’s IP industry lead in bioinformatics and bioIT, Antonia represents biotech companies with technology that includes software platforms, artificial intelligence (AI) or machine learning models, and virtual or augmented reality (VR/AR).
In addition, Antonia heads up the firm’s digital health patent practice, with strong expertise in telehealth and mHealth, EMRs, and patient and physician software platforms and mobile apps.
As Fenwick’s IP industry lead in bioinformatics and bioIT, Antonia represents biotech companies with technology that includes software platforms, artificial intelligence (AI) or machine learning models, and virtual or augmented reality (VR/AR).
In addition, Antonia heads up the firm’s digital health patent practice, with strong expertise in telehealth and mHealth, EMRs, and patient and physician software platforms and mobile apps.
Antonia is also a leading attorney in biotech and medical devices, with experience representing companies in surgical devices, dental devices, diagnostic assays, laboratory instruments, robotics, microfluidics, organ chips, drug delivery devices and nanopore technology.
Antonia is also a leading attorney in biotech and medical devices, with experience representing companies in surgical devices, dental devices, diagnostic assays, laboratory instruments, robotics, microfluidics, organ chips, drug delivery devices and nanopore technology.
Recognition Recognition Recognition
Recognition Recognition Recognition
Antonia's work has resulted in ongoing honors and awards within the legal field:
2023
Shortlisted for Practitioner of the Year for Patent Prosecution - United States; named a Patent Star
2024
Ranks Antonia as a top lawyer for patent prosecution in California
2024
Leading lawyer for California: Intellectual Property: Patent Prosecution
2024
Recognized for Patents: Prosecution (including re-examination and post-grant proceedings)